Adoptive immunotherapy of ovarian carcinoma

被引：21

作者：

de Gramont, A ^{[1
]}

Gangji, D

Louvet, C

Garcia, ML

Tardy, D

Romet-Lemonne, JL

机构：

[1] Hop St Antoine, F-75571 Paris, France

[2] Hop Erasme, Brussels, Belgium

[3] Immuno Designed Mol, Paris, France

来源：

GYNECOLOGIC ONCOLOGY | 2002年 / 86卷 / 01期

关键词：

D O I：

10.1006/gyno.2002.6667

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：102 / 103

页数：2

相关论文

共 5 条

[1]

[Anonymous], 1979, HDB REP RES CANC TRE

[2]

PATHOGENESIS OF OVARIAN CANCERS [J].

BERCHUCK, A ;

ELBENDARY, A ;

HAVRILESKY, L ;

RODRIGUEZ, GC ;

BAST, RC .

JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1994, 1 (03) :181-190

[3]

LARGE-SCALE ISOLATION OF HUMAN BLOOD MONOCYTES BY CONTINUOUS-FLOW CENTRIFUGATION LEUKAPHERESIS AND COUNTERFLOW CENTRIFUGATION ELUTRIATION FOR ADOPTIVE CELLULAR IMMUNOTHERAPY IN CANCER-PATIENTS [J].

FARADJI, A ;

BOHBOT, A ;

SCHMITTGOGUEL, M ;

SIFFERT, JC ;

DUMONT, S ;

WIESEL, ML ;

PIEMONT, Y ;

EISCHEN, A ;

BERGERAT, JP ;

BARTHOLEYNS, J ;

POINDRON, P ;

WITZ, JP ;

OBERLING, F .

JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 174 (1-2) :297-309

[4]

FIDLER I, 1990, CANCER RES, V45, P4714

[5]

PHASE IA/IB TRIAL OF BISPECIFIC ANTIBODY MDX-210 IN PATIENTS WITH ADVANCED BREAST OR OVARIAN-CANCER THAT OVEREXPRESSES THE PROTOONCOGENE HER-2/NEU [J].

VALONE, FH ;

KAUFMAN, PA ;

GUYRE, PM ;

LEWIS, LD ;

MEMOLI, V ;

DEO, Y ;

GRAZIANO, R ;

FISHER, JL ;

MEYER, L ;

MROZEKORLOWSKI, M ;

WARDWELL, K ;

GUYRE, V ;

MORLEY, TL ;

ARVIZU, C ;

FANGER, MW .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2281-2292